Nageen Sharma
Craniosacral therapy
Faisalabad, Punjab, Pakistan
Years of experience 3

Total years in practice: 3

Published Date
December 31, 2015
Abstract Authors
Rainer Kraehenmann, André Schmidt, Karl Friston, Katrin H Preller, Erich Seifritz, Franz X Vollenweider
Abstract Source
Neuroimage Clin. 2016 ;11:53-60. Epub 2015 Aug 22. PMID: 26909323
Abstract Affiliation
Rainer Kraehenmann
Study Type
Research
Conditions
Anxiety Disorders, Depression
Therapies
Functional Medicine, Naturopathic Medicine
Reference
Abstract Content
Stimulation of serotonergic neurotransmission by psilocybin has been shown to shift emotional biases away from negative towards positive stimuli. We have recently shown that reduced amygdala activity during threat processing might underlie psilocybin's effect on emotional processing. However, it is still not known whether psilocybin modulates bottom-up or top-down connectivity within the visual-limbic-prefrontal network underlying threat processing. We therefore analyzed our previous fMRI data using dynamic causal modeling and used Bayesian model selection to infer how psilocybin modulated effective connectivity within the visual-limbic-prefrontal network during threat processing. First, both placebo and psilocybin data were best explained by a model in which threat affect modulated bidirectional connections between the primary visual cortex, amygdala, and lateral prefrontal cortex. Second, psilocybin decreased the threat-induced modulation of top-down connectivity from the amygdala to primary visual cortex, speaking to a neural mechanism that might underlie putative shifts towards positive affect states after psilocybin administration. These findings may have important implications for the treatment of mood and anxiety disorders.
Get a Consultation
(650) 539-4545
Get more information via email